Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus
NCT03589443
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Barrett Esophagus
Interventions
DRUG:
Multiplexed heptapeptides
Sponsor
University of Michigan